Nathan S. Teuscher

536 total citations
25 papers, 448 citations indexed

About

Nathan S. Teuscher is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Nathan S. Teuscher has authored 25 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Nathan S. Teuscher's work include Attention Deficit Hyperactivity Disorder (5 papers), Biochemical effects in animals (5 papers) and Nigella sativa pharmacological applications (4 papers). Nathan S. Teuscher is often cited by papers focused on Attention Deficit Hyperactivity Disorder (5 papers), Biochemical effects in animals (5 papers) and Nigella sativa pharmacological applications (4 papers). Nathan S. Teuscher collaborates with scholars based in United States, Germany and France. Nathan S. Teuscher's co-authors include Richard F. Keep, David E. Smith, Alexander Novotny, Jianming Xiang, Hong Shen, Walter Stummer, David E. Smith, Akwete Adjei, Sharon B. Wigal and Laurence L. Greenhill and has published in prestigious journals such as Gastroenterology, Journal of Neurochemistry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Nathan S. Teuscher

25 papers receiving 438 citations

Peers

Nathan S. Teuscher

ONCOL

MB

PPCH

BIOCH

PHYSI

Tatsuya Kikuchi Japan

David Dickens United Kingdom

Emi Hayashinaka Japan

Maria Ribadeneira United States

Sylvain Auvity France

Kouichi Kawazu Japan

Scott M. Ocheltree United States

Gavin Brown United Kingdom

T. Okamura Japan

M HONG Canada

Tatsuya Kikuchi Japan

Nathan S. Teuscher

143 ×0.8

ONCOL

129 ×1.3

MB

58 ×0.6

PPCH

49 ×0.6

BIOCH

50 ×0.7

PHYSI

Citations per year, relative to Nathan S. Teuscher Nathan S. Teuscher (= 1×) peers Tatsuya Kikuchi

Countries citing papers authored by Nathan S. Teuscher

Since Specialization

Citations

This map shows the geographic impact of Nathan S. Teuscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan S. Teuscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan S. Teuscher more than expected).

Fields of papers citing papers by Nathan S. Teuscher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan S. Teuscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan S. Teuscher. The network helps show where Nathan S. Teuscher may publish in the future.

Co-authorship network of co-authors of Nathan S. Teuscher

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan S. Teuscher. A scholar is included among the top collaborators of Nathan S. Teuscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan S. Teuscher. Nathan S. Teuscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kovar, Andreas, et al.. (2023). Sutimlimab Pharmacokinetics and Pharmacodynamics in Patients with Cold Agglutinin Disease. Journal of Pharmacology and Experimental Therapeutics. 386(2). 143–155. 2 indexed citations

2.

Teuscher, Nathan S.. (2023). The history and future of population pharmacokinetic analysis in drug development. Xenobiotica. 54(7). 394–400. 4 indexed citations

3.

Shen, Jun, Daniel Tatosian, Nathan S. Teuscher, et al.. (2022). POPULATION PHARMACOKINETICS OF OZANIMOD AND ACTIVE METABOLITE CC112273 IN PATIENTS WITH ULCERATIVE COLITIS. Gastroenterology. 162(3). S17–S18. 1 indexed citations

4.

Shen, Jun, Daniel Tatosian, Nathan S. Teuscher, et al.. (2022). POPULATION PHARMACOKINETICS OF OZANIMOD AND ACTIVE METABOLITE CC112273 IN PATIENTS WITH ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 28(Supplement_1). S17–S18. 1 indexed citations

5.

Noronha, Glenn, et al.. (2020). PK model with concentration-dependent clearance for zuretinol acetate, an oral agent in development for treatment of inherited retinal dystrophy caused by LRAT or RPE65 mutations. 61(7). 4942–4942. 1 indexed citations

6.

Corrigan, Brian, Robert Fox, Jill Fiedler‐Kelly, et al.. (2018). Data standards for model-informed drug development: an ISoP initiative. Journal of Pharmacokinetics and Pharmacodynamics. 45(5). 659–661. 2 indexed citations

7.

Guzy, Serge, et al.. (2018). A distributed delay approach for modeling delayed outcomes in pharmacokinetics and pharmacodynamics studies. Journal of Pharmacokinetics and Pharmacodynamics. 45(2). 285–308. 16 indexed citations

8.

Teuscher, Nathan S., et al.. (2017). 6.37 Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 56(10). S288–S289. 2 indexed citations

9.

Teuscher, Nathan S., Akwete Adjei, Robert L. Findling, et al.. (2015). Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder. Drug Design Development and Therapy. 9. 2767–2767. 12 indexed citations

10.

Adjei, Akwete, Nathan S. Teuscher, Robert Kupper, et al.. (2014). Single-Dose Pharmacokinetics of Methylphenidate Extended-Release Multiple Layer Beads Administered as Intact Capsule or Sprinkles Versus Methylphenidate Immediate-Release Tablets (Ritalin ^® ) in Healthy Adult Volunteers. Journal of Child and Adolescent Psychopharmacology. 24(10). 570–578. 24 indexed citations

11.

Adjei, Akwete, Robert Kupper, Nathan S. Teuscher, et al.. (2014). Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers. Clinical Drug Investigation. 34(11). 795–805. 17 indexed citations

12.

Teuscher, Nathan S., et al.. (2013). A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteers. Clinical Pharmacology in Drug Development. 3(4). 314–320. 6 indexed citations

13.

Teuscher, Nathan S., et al.. (2012). A Novel Study Using Accelerated Mass Spectrometry to Evaluate the Pharmacokinetics of Total ¹⁴C AL‐8309 (Tandospirone) Following Topical Ocular Administration in Healthy Male Subjects. Clinical Pharmacology in Drug Development. 1(1). 4–13. 4 indexed citations

14.

Lindstrom, Richard L., Stephen S. Lane, Andrew J. Cottingham, et al.. (2010). Conjunctival Concentrations of a New Ophthalmic Solution Formulation of Moxifloxacin 0.5% in Cataract Surgery Patients. Journal of Ocular Pharmacology and Therapeutics. 26(6). 591–595. 4 indexed citations

15.

Teuscher, Nathan S., et al.. (2004). Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice. Journal of Neurochemistry. 89(2). 375–382. 40 indexed citations

16.

Teuscher, Nathan S., et al.. (2004). Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice. Journal of Neurochemistry. 91(4). 1024–1024. 2 indexed citations

17.

Shen, Hong, et al.. (2002). Role of PEPT2 in Peptide/Mimetic Trafficking at the Blood-Cerebrospinal Fluid Barrier: Studies in Rat Choroid Plexus Epithelial Cells in Primary Culture. Journal of Pharmacology and Experimental Therapeutics. 301(3). 820–829. 82 indexed citations

18.

Teuscher, Nathan S., Richard F. Keep, & David E. Smith. (2001). PEPT2-Mediated Uptake of Neuropeptides in Rat Choroid Plexus. Pharmaceutical Research. 18(6). 807–813. 51 indexed citations

19.

Novotny, Alexander, Jianming Xiang, Walter Stummer, et al.. (2000). Mechanisms of 5‐Aminolevulinic Acid Uptake at the Choroid Plexus. Journal of Neurochemistry. 75(1). 321–328. 98 indexed citations

20.

Teuscher, Nathan S., Alexander Novotny, Richard F. Keep, & David E. Smith. (2000). Functional Evidence for Presence of PEPT2 in Rat Choroid Plexus: Studies with Glycylsarcosine. Journal of Pharmacology and Experimental Therapeutics. 294(2). 494–499. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact